Mall owners are increasingly building out food halls with local chef-driven eateries, sushi bars and premium coffee shops.Retailread more
Most U.S. hedge funds aren't expecting another big stock market sell-off as more firms curb bets on volatility, according to Nomura.Marketsread more
While Trump's lawyers had argued that the committee's subpoena did not have a legitimate legislative purpose — and was therefore invalid — Mehta took a broader view.Politicsread more
See which stocks are posting big moves after the bell on Monday, May 20.Market Insiderread more
Silicon Valley argues that Wall Street focuses too much on near-term profits — but investors have embraced money-losing biotech IPOs.Marketsread more
Iran has quadrupled its output of nuclear material amid rising tension with the U.S. and dangerous escalations in the Middle East.Energyread more
The issue of corporate debt has surfaced as companies continue to use the low rates the Fed has provided to lever up their balance sheets.The Fedread more
The announcement comes amid a wave of store closures across the country this year.Retailread more
"Unlike Bernie Sanders or Elizabeth Warren or Kamala Harris, Biden's against 'Medicare for All,'" the "Mad Money" host says.Mad Money with Jim Cramerread more
"As long as President [Donald] Trump believes that the Chinese are the ones who pay the price, he's going to keep taking a hard-line approach to these negotiations," Cramer...Mad Money with Jim Cramerread more
Sens. Mitch McConnell and Tim Kaine introduced a bill Monday that would raise the minimum age to buy tobacco to 21 in hopes of curbing what regulators are calling an...Health and Scienceread more
A small private equity fund devoted to the growth of the marijuana industry is getting a big boost from its stake in Tilray.
Shares of Tilray nearly doubled at one point on Wednesday in volatile trading that included multiple trading halts. But it was the third straight day of gains. On Tuesday, the company said it had the okay from the U.S. Drug Enforcement Administration to import medical marijuana for a clinical trial in California. The stock only began trading publicly in July.
Seattle-based Privateer Holdings has at least a 76 percent stake in Tilray, according to FactSet. Earlier this year, the fund raised $100 million, bringing the total amount it has raised since 2010 to $200 million. Privateer has disclosed investments in four cannabis-related companies, including Tilray and Leafly, Marley Natural and The Goodship.
Leafly is a social network on which users can share advice on different products and dispensaries. Tilray produces and distributes cannabis and researches ways to use it. The two others make products containing cannabis, such as hand cream and chocolate.
The surge of interest in companies that are connected to the marijuana industry comes as a few large consumer product companies step into the mix. Constellation Brands, the maker of Corona beer, has an 8 percent stake in Canopy Growth, Canada's largest medical marijuana producer. Shares of Canopy also had a wild ride on Wednesday but closed down nearly 5 percent. Coca-Cola has also said it was looking at the industry.
A spokesman for Privateer said the firm didn't want to comment on Tilray's stock moves.
Privateer has raised money in prior rounds from Founders Fund, the firm run by Silicon Valley mogul Peter Thiel, and other small funds such as Subversive Capital, whose Michael Auerbach sits on Tilray's board as well as Privateer's board.
Privateer founders Brendan Kennedy, Michael Blue and Christian Groh have committed their own money to "help communities harmed by cannabis prohibition," according to a firm announcement earlier this year.